Accolade Management

Management criteria checks 3/4

Accolade's CEO is Raj Singh, appointed in Oct 2015, has a tenure of 8.5 years. total yearly compensation is $2.00M, comprised of 25% salary and 75% bonuses, including company stock and options. directly owns 0.96% of the company’s shares, worth €5.53M. The average tenure of the management team and the board of directors is 3.1 years and 4.7 years respectively.

Key information

Raj Singh

Chief executive officer

US$2.0m

Total compensation

CEO salary percentage	25.0%
CEO tenure	8.5yrs
CEO ownership	1.0%
Management average tenure	3.1yrs
Board average tenure	4.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Raj Singh's remuneration changed compared to Accolade's earnings?
Date	Total Compensation	Salary	Company Earnings
Feb 29 2024	n/a	n/a	-US$100m
Nov 30 2023	n/a	n/a	-US$123m
Aug 31 2023	n/a	n/a	-US$142m
May 31 2023	n/a	n/a	-US$155m
Feb 28 2023	US$2m	US$500k	-US$460m
Nov 30 2022	n/a	n/a	-US$464m
Aug 31 2022	n/a	n/a	-US$401m
May 31 2022	n/a	n/a	-US$417m
Feb 28 2022	US$6m	US$471k	-US$123m
Nov 30 2021	n/a	n/a	-US$93m
Aug 31 2021	n/a	n/a	-US$132m
May 31 2021	n/a	n/a	-US$85m
Feb 28 2021	US$3m	US$400k	-US$51m
Nov 30 2020	n/a	n/a	-US$48m
Aug 31 2020	n/a	n/a	-US$50m
May 31 2020	n/a	n/a	-US$49m
Feb 29 2020	US$3m	US$394k	-US$51m
Nov 30 2019	n/a	n/a	-US$56m
Feb 28 2019	US$574k	US$350k	-US$56m

Compensation vs Market: Raj's total compensation ($USD2.00M) is above average for companies of similar size in the German market ($USD1.29M).

Compensation vs Earnings: Raj's compensation has been consistent with company performance over the past year.

CEO

Raj Singh (54 yo)

8.5yrs

Tenure

US$1,998,407

Compensation

Mr. Rajeev Singh, also known as Raj, serves as Director at Amperity, Inc. He has been the Chief Executive Officer and Executive Director of Accolade, Inc. since October 2015 and also serves as its Chairman...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Rajeev Singh	Chairman of the Board & CEO	8.5yrs	US$2.00m	0.96% $ 5.5m
Robert Cavanaugh	President	5.3yrs	US$1.13m	0.22% $ 1.3m
Stephen Barnes	CFO & Treasurer	9.2yrs	US$1.14m	0.23% $ 1.3m
Kristen Bruzek	Senior Vice President of Operations	less than a year	no data	no data
Colin McHugh	Chief Accounting Officer	less than a year	no data	0.047% $ 274.0k
Todd Friedman	Senior Vice President of Investor Relations	3.5yrs	no data	no data
Richard Eskew	Executive VP	6yrs	no data	0.050% $ 288.7k
Kelsi McDonald Harris	Chief People Officer & Senior Vice President	less than a year	no data	no data
Drew Garner	Executive Vice President of Engineering	2.3yrs	no data	no data
Shantanu Nundy	Executive VP	4.3yrs	no data	no data
James Wantuck	Senior VP & Chief Medical Officer - Care	less than a year	no data	no data
Ryan McQuaid	Executive Vice President & Chief Product Officer	2.7yrs	no data	no data

3.1yrs

Average Tenure

51yo

Average Age

Experienced Management: 4NE1's management team is considered experienced (3.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Rajeev Singh	Chairman of the Board & CEO	8.5yrs	US$2.00m	0.96% $ 5.5m
Shantanu Nundy	Executive VP	5.3yrs	no data	no data
Dawn Lepore	Independent Director	4.8yrs	US$237.00k	0% $ 0
Jeffrey Jordan	Independent Director	7.8yrs	US$222.00k	0.024% $ 137.4k
Michael Hilton	Director	1.2yrs	US$706.70k	0.44% $ 2.5m
Patricia Wadors	Independent Director	4.2yrs	US$222.00k	0.024% $ 137.4k
Peter Klein	Lead Independent Director	4.6yrs	US$262.00k	0.025% $ 141.6k
Larry Kaiser	Member of Medical Advisory Board	no data	no data	no data
Jeffrey Brodsky	Independent Director	2.8yrs	US$222.00k	0.037% $ 213.9k
Joseph Betancourt	Member of Medical Advisory Board	no data	no data	no data
Saul Weiner	Member of Medical Advisory Board	no data	no data	no data
Jennifer Lerner	Member of Medical Advisory Board	no data	no data	no data

4.7yrs

Average Tenure

58yo

Average Age

Experienced Board: 4NE1's board of directors are considered experienced (4.7 years average tenure).

Accolade Management

Management criteria checks 3/4

Key information

Recent management updates

Accolade, Inc. Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

Accolade, Inc., Annual General Meeting, Aug 08, 2023

Accolade, Inc. Announces Changes to Its Board of Directors

Chairman of the Board & CEO recently bought €173k worth of stock

Accolade, Inc. Appoints Kelli Burns as Senior Vice President, Chief Information Security Officer

Recent updates

Full year 2024 earnings released: US$1.33 loss per share (vs US$6.45 loss in FY 2023)

Accolade, Inc. to Report Q4, 2024 Results on Apr 25, 2024

Accolade, Inc. Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President

Third quarter 2024 earnings released: US$0.28 loss per share (vs US$0.56 loss in 3Q 2023)

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ending February 29, 2024 and Year Ending February 28, 2025

Accolade, Inc. to Report Q3, 2024 Results on Jan 08, 2024

Second quarter 2024 earnings released: US$0.43 loss per share (vs US$0.66 loss in 2Q 2023)

Accolade, Inc. to Report Q2, 2024 Results on Oct 04, 2023

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

First quarter 2024 earnings released: US$0.53 loss per share (vs US$4.92 loss in 1Q 2023)

Accolade, Inc., Annual General Meeting, Aug 08, 2023

Accolade, Inc. to Report Q1, 2024 Results on Jun 29, 2023

Full year 2023 earnings released: US$6.45 loss per share (vs US$1.93 loss in FY 2022)

Accolade, Inc. Announces Changes to Its Board of Directors

Third quarter 2023 earnings released: US$0.56 loss per share (vs US$0.34 profit in 3Q 2022)

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending February 28, 2023; Provides Earnings Guidance for the Year Ending February 29, 2024

Accolade, Inc. to Report Q3, 2023 Results on Jan 09, 2023

Second quarter 2023 earnings released: US$0.66 loss per share (vs US$0.97 loss in 2Q 2022)

Accolade, Inc. Provides Revenue Guidance for the Fiscal Third Quarter Ending November 30, 2022 and Fiscal Year Ending February 28, 2023

Accolade, Inc. to Report Q2, 2023 Results on Oct 06, 2022

Chairman of the Board & CEO recently bought €173k worth of stock

Accolade, Inc. Appoints Kelli Burns as Senior Vice President, Chief Information Security Officer

Accolade, Inc. Provides Earnings Guidance for Second Quarter Ending August 31, 2022 and Fiscal Year Ending February 28, 2023

Accolade, Inc.(NasdaqGS:ACCD) dropped from Russell 2000 Growth Index

Accolade, Inc., Annual General Meeting, Jul 26, 2022

Accolade, Inc. to Report Q1, 2023 Results on Jun 30, 2022

Accolade, Inc. announced delayed annual 10-K filing

Full year 2022 earnings released: US$1.93 loss per share (vs US$1.73 loss in FY 2021)

Accolade, Inc. to Report Q4, 2022 Results on Apr 28, 2022

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter, Fiscal Year Ending February 28, 2022 and Fiscal Year 2023

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Second quarter 2022 earnings released: US$0.97 loss per share (vs US$0.47 loss in 2Q 2021)

Accolade Introduces Personalized Healthcare Category

High number of new directors

High number of new directors

First quarter 2022 earnings released: US$0.84 loss per share (vs US$1.86 loss in 1Q 2021)

Accolade, Inc.(NasdaqGS:ACCD) dropped from Russell 2500 Value Index

Accolade, Inc. (NasdaqGS:ACCD) completed the acquisition of PlushCare, Inc.

Independent Chairman J. Cline has left the company

Independent Director William Frist has left the company

Full year 2021 earnings released: US$1.73 loss per share (vs US$9.13 loss in FY 2020)

Accolade, Inc. Provides Earnings Guidance for the First Quarter Ending May 31, 2021 and Fiscal Year Ending February 28, 2022

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age